🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to message these accounts directly for source information, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where communities with numerous of members share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers promote the drug there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Express Worries

However, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering substances of unknown origin.

Some professionals said the demand for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Removal

According to TikTok, the platform has taken down violative content and banned associated hashtags and search suggestions. The company said it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of users, filled with images of slimming results, positive testimonials and detailed instructions for preparing or injecting at home.

Within moments of joining one group, a vendor shared WhatsApp details, where most purchases take place. The vendor sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Details and Costs

Inside these groups, posts display dark colored packages with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service said it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they can’t verify. Even if the science behind this drug is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has already encountered individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to potentially significant health risks”.